ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES
NCT06753942
·
clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Immune-mediated Diseases
Glomerulonephritis
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna